Oxford Pharmascience Group Plc | Medicines made better

 

Pipeline

All products in Oxford Pharmascience's pipeline target unmet patient needs with strong commercial potential in global markets and are supported with associated intellectual property and stringent proprietary science and preclinical/clinical data.

These products are created by combining proprietary formulation technology with proven, marketed drugs, resulting in reduced development risks and costs and a faster time to market.

The pipeline is focused on pain relief and cardiovascular disease indications, with lead programmes in NSAIDs (Ibuprofen, Naproxen, Diclofenac).

Pipeline